StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Price Performance Shares of Ampio Pharmaceuticals stock opened at $2.25 on Friday. The business has a fifty day simple moving average of $2.31 […]
Ampio Provides Litigation Update - Reports Settlement In Principle Of Certain Pending Legal Actions menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the stock. Ampio Pharmaceuticals Stock Up 1.5 % NYSE AMPE opened at $2.08 on Friday. The company has a 50-day simple moving average of $2.37 and a two-hundred […]